Skip to content

Postoperative analgesia for supratentorial craniotomy

Postoperative analgesia for supratentorial craniotomy: a randomised controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN15818652
Enrollment
83
Registered
2015-04-27
Start date
2013-07-01
Completion date
Unknown
Last updated
2016-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Post-supratentorial craniotomy pain Signs and Symptoms Acute pain

Interventions

Participants are allocated to one of four groups. All patients receive morphine-based patient controlled analgesia for 24 hours following surgery, in addition to one of the following: 1. Intravenous d

Sponsors

University of Istanbul
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. American Society of Anesthesiology (ASA) classification I-II or III 2. Aged 18 - 70 2. Scheduled for elective supratentorial craniotomy

Exclusion criteria

Exclusion criteria: 1. Neurological disorders hindering communication 2. Aphasia 3. Glasgow Coma Score (GCS) less than 15 4. Drug or alcohol addiction 5. Chronic pain 6. Raised intracranial pressure 7. Allergies to any of the drugs used in this study 8. Hepatic or renal dysfunction 9. Peptic ulcer disease 10. Dementia

Design outcomes

Primary

MeasureTime frame
Pain intensity is assessed during the first 24 hours post-surgery using the visual analogue scale (VAS) (at the 10th minute, 1, 2, 6, 12, and 24 hours postoperatively).

Secondary

MeasureTime frame
Assessed during the first 24 hours post-surgery (at the 10th minute, 1, 2, 6, 12, and 24 hours postoperatively): 1. Morphine consumption 2. Morphine-related side effects 3. Ramsay Sedation Scale (RSS) 4. Blood pressure 5. Heart/respiratory rate

Countries

Turkey

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026